SPONSOR
Universidade Federal Fluminense
Total Trials
4
Recruiting
4
Phases
Phase 4
Conditions studied: Systemic Arterial HypertensionInflammationSpastic ParaplegiaCardiovascular DiseasesDyslipidemiasKidney Failure, ChronicOxidative StressHemodialysis
Universidade Federal Fluminense is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Systemic Arterial Hypertension, Inflammation, Spastic Paraplegia, Cardiovascular Diseases.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universidade Federal Fluminense
How many clinical trials has Universidade Federal Fluminense sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Universidade Federal Fluminense, of which 4 are actively recruiting participants. These trials cover conditions including Systemic Arterial Hypertension, Inflammation, Spastic Paraplegia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universidade Federal Fluminense research focus on?
Universidade Federal Fluminense clinical trials span Systemic Arterial Hypertension, Inflammation, Spastic Paraplegia, Cardiovascular Diseases, Dyslipidemias, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universidade Federal Fluminense clinical trial?
To participate in a Universidade Federal Fluminense trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universidade Federal Fluminense trials with current recruitment status updated daily.
Clinical Trials by Universidade Federal Fluminense
NCT07596966
Recruiting
EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION
Systemic Arterial Hypertension
NCT07803276 Phase 4
Recruiting
Comparison Between Palpatory and Ultrasound-guided Methods for Botulinum Toxin Administration in Spastic Paraplegia
Spastic Paraplegia
NCT06183307
Recruiting
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Cardiovascular Diseases
NCT06438445
Recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Kidney Failure, Chronic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology